On-demand webinar

Shaping the future of SCEs:

The evolution of statistical computing environments

Watch on demand

Our expert panelists at Domino and UCB will explore the key challenges driving SCE transformation for life sciences organizations, dive into the latest technological innovations, and help you understand governance's critical role in ensuring compliance, while optimizing workflows. Learn how to navigate this rapidly changing SCE landscape and leverage global collaboration to drive the next wave of innovation.

Watch this on-demand webinar and you’ll discover:

  • Key challenges of legacy SCE technology and the evolution of SCE
  • What’s new with today’s SCE technology – ways to enhance efficiency and collaboration
  • Why strong governance is critical in maintaining regulatory compliance and streamlining workflows
  • How to build a global network of collaboration, fueling innovation and progress
  • Top practices and future-proof SCE strategies to advance and drive clinical studies forward

Featured Speakers

Tim Williams

Tim Williams

Statistical Solutions Lead, UCB

UCB logo

Biologist turned Computer Systems Analyst, Tim’s career spans over 30 years in the Life Sciences. His experience ranges from mentoring programmers in Mumbai to leading interactive Knowledge Graph Workshops and volunteering with the PHUSE organization. His skills include analysis programming for clinical trials, systems administration, validation, and deployment. He is a certified Professional Scrum Product Owner.

Chris McSpiritt

Chris McSpiritt

VP of Strategy, Life Sciences, Domino

Domino Data Lab logo

Christopher McSpiritt is a seasoned business architect, consultant, and product leader who has spent almost two decades specializing in helping life sciences organizations improve drug development processes through process reengineering efforts and the deployment of innovative software/analytics solutions. As VP of Life Sciences Strategy at Domino Data Lab, he leads Domino's go-to-market and product strategy for the pharmaceutical industry.